Influence of lactate on isoproterenol-induced lipolysis and beta-adrenoceptors distribution in human fat cells.
The influence of lactate on human adipocytes lipolysis and the possible relationship between lactate-induced metabolic effects and beta-adrenoceptor binding sites were investigated. beta-sites were identified in membranes with (125I)-cyanopindolol and in intact cells with (125I)-cyanopindolol and (3H)-CGP 12177. Lactate reduced isoproterenol-induced lipolysis in a dose-response fashion and such inhibition became significant only at 16 mmol/l lactate. Exposure of human fat cells to 16 mmol/l lactate significantly reduced beta-adrenoceptors density on crude membranes. When the binding assay was performed on intact cells using (125I)-cyanopindolol at 37 degrees C, the radioligand identified the same number of receptors, regardless of the presence of lactate in the preincubation medium. When (3H)-CGP 12177 was used, it bound to about 35% less receptors in lactate pre-treated cells than in control. Seemingly, at 37 degrees C, because of its lipophilicity, (125I)-cyanopindolol can cross the plasma membrane and bind to intracellular sites whereas, (3H)-CGP 1277, due to its hydrophilicity, identifies surface receptors only. Thus, the present in vitro study provides evidence that high levels of lactate, similar to the concentrations usually achieved in overt lactic acidosis, are able per se to inhibit human lipolysis and to redistribute beta-adrenoceptors from cell surface to a domain not accessible to hydrophilic ligands.
De Pergola
G
G
Clinica Medica III e Cattedra di Endocrinologia, Università degli Studi di Bari, Italy.
Cignarelli
M
M
Nardelli
G
G
Garruti
G
G
Corso
M
M
Di Paolo
S
S
Cardone
F
F
Giorgino
R
R
D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002478:Cells, Cultured; D006801:Humans; D007545:Isoproterenol / Q000494:pharmacology*; D007773:Lactates / Q000494:pharmacology*; D008066:Lipolysis / Q000187:drug effects*; D008875:Middle Aged; D010869:Pindolol / Q000031:analogs & derivatives; D011412:Propanolamines / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism; D012702:Serotonin Antagonists
D000319:Adrenergic beta-Antagonists; D007773:Lactates; D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; D012702:Serotonin Antagonists; C047975:cyanopindolol; D010869:Pindolol; D007545:Isoproterenol; C033394:CGP 12177